...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Novel biosensing system for the simultaneous multiplex fluorescent determination of catecholamines and their metabolites in biological liquids
【24h】

Novel biosensing system for the simultaneous multiplex fluorescent determination of catecholamines and their metabolites in biological liquids

机译:用于同时复用荧光法测定儿茶酚胺及其在生物液体中代谢物的新型生物传感系统

获取原文
获取原文并翻译 | 示例
           

摘要

A novel original biosensing system for the simultaneous multiplex determination of general markers of catecholamine-producing diseases - catecholamines (dopamine, epinephrine, norepinephrine) and their metabolites (homovanillic and vanillylmandelic acids) in biological liquids without preliminary separation of analytes, in the absence of specific antibodies and receptors and with minimum pretreatment of a samples has been developed. This outstanding approach includes the unique combination of obtaining highly fluorescent derivatives of the analytes as a result of their interaction with two different amines - benzylamine and 1,2-diphenylethylenediamine in the presence of peroxidase as a catalyst, with the application of first-order derivative fluorescence spectroscopy for the resolution of their spectra. Fluorescence is measured in 96-well microplates, which wells contain a bio-recognizing film consisted of horseradish peroxidase immobilized in the polymer chitosan. Spectra of the solutions are recorded in the range 400-500 nm (lambda(ex) similar to 305-356 nm). The proposed procedures provide sensitive (in the range of 3-200 nM), selective, and reproducible (RSDs = 1%, n = 6) multiplex determination of the catecholamines and their metabolites in biological liquids were successfully applied for the rapid simultaneous (20 samples per 15-30 min) screening of human urine and mice blood plasma. The validated results showed good linearity, precision, accuracy and selectivity of this method. (C) 2018 Elsevier B.V. All rights reserved.
机译:用于同时多重测定儿茶酚胺产生的疾病的一般标记的一种新颖的原生物感测系统 - 儿茶酚胺(多巴胺,肾上腺素,去甲肾上腺素)和它们在生物液体中的代谢物(高香草和香草扁桃酸),而不分析物的初步分离,在没有特定的抗体和受体,并用最小样本预处理已经研制成功。这一优异的方法包括:获得被分析物的高度荧光衍生物作为它们与两种不同的胺相互作用的结果的独特组合 - 苄胺和在过氧化物酶的存在作为催化剂的1,2-二苯基乙二胺,与一阶导数的应用荧光光谱法对它们的光谱分辨率。荧光在96孔微量培养板,其孔含有一个生物识别膜上测量由辣根过氧化物酶固定于聚合物脱乙酰壳多糖。溶液的光谱被记录在范围400-500纳米(拉姆达(EX)类似于305-356纳米)。所提出的过程提供了敏感(在3-200纳米范围内),选择性,和可重复的(相对标准偏差< = 1%,N = 6)的儿茶酚胺和它们在生物液体中代谢物的多重测定成功应用的快速同步(每15-30分钟20个样品)筛选人尿和小鼠血浆。该验证结果表明,线性好,精密度,准确度和该方法的选择性。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号